A phase 2/3, randomized, double-masked, sham-controlled trial of QPI-1007 delivered by single or multi-dose intravitreal injection(s) to subjects with acute nonarteritic anterior ischemic optic neuropathy (NAION),
Role: Investigator,
Quark Pharmaceuticals,
(01/2019 - 01/2020)
Status: Completed
The efficacy and safety of Bimatoprost SR in patients with open-angle glaucoma or ocular hypertension,
Role: Investigator,
Allergan Inc.,
(01/2019 - 01/2020)
Status: Completed